Is Cour a buy?

Out of 16 analysts, 9 (56.25%) are recommending COUR as a Strong Buy , 6 (37.5%) are recommending COUR as a Buy, 1 (6.25%) are recommending COUR as a Hold, 0 (0%) are recommending COUR as a Sell, and 0 (0%) are recommending COUR as a Strong Sell.

Sizin İçin Seçtik  Ağır engelli raporu hangi hastalıklara verilir?

Leave a Reply

Your email address will not be published. Required fields are marked *